Support Your Preclinical and Clinical Studies with De Novo Lipogenesis Assay
Understanding liver metabolic activity is a cornerstone of advancing research into conditions like obesity, non-alcoholic steatohepatitis (NASH), and other metabolic disorders. The liver’s role in synthesizing fatty acids through de novo lipogenesis (DNL) offers critical insights into metabolic health, disease progression, and therapeutic intervention.
